Integration of HIV and TB Services Results in Improved TB Treatment Outcomes and Earlier Prioritized ART Initiation in a Large Urban HIV Clinic in Uganda

BACKGROUND:The World Health Organization recommends that treatment of tuberculosis (TB) in HIV-infected patients should be integrated with HIV care. In December 2008, a separate outdoor-integrated TB/HIV clinic was instituted for attendees of a large urban HIV clinic in Uganda. We sought to evaluate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of acquired immune deficiency syndromes (1999) 2012-06, Vol.60 (2), p.e29-e35
Hauptverfasser: Hermans, Sabine M, Castelnuovo, Barbara, Katabira, Catherine, Mbidde, Peter, Lange, Joep M A, Hoepelman, Andy I M, Coutinho, Alex, Manabe, Yukari C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e35
container_issue 2
container_start_page e29
container_title Journal of acquired immune deficiency syndromes (1999)
container_volume 60
creator Hermans, Sabine M
Castelnuovo, Barbara
Katabira, Catherine
Mbidde, Peter
Lange, Joep M A
Hoepelman, Andy I M
Coutinho, Alex
Manabe, Yukari C
description BACKGROUND:The World Health Organization recommends that treatment of tuberculosis (TB) in HIV-infected patients should be integrated with HIV care. In December 2008, a separate outdoor-integrated TB/HIV clinic was instituted for attendees of a large urban HIV clinic in Uganda. We sought to evaluate associated TB and HIV treatment outcomes. METHODS:Routinely collected clinical, pharmacy, and laboratory data were merged with TB clinic data for patients initiating TB treatment in 2009 and with TB register data for patients in 2007. TB treatment outcomes and (timing of) antiretroviral therapy (ART) initiation in ART-naive patients [overall and stratified by CD4+ T cell (CD4) count] in 2007 and 2009 were compared. Nosocomial transmission rates could not be assessed. RESULTS:Three hundred forty-six patients were initiated on TB treatment in 2007 and 366 in 2009. Median CD4 counts at TB diagnosis did not differ. TB treatment cure or completion increased from 62% to 68%, death or default decreased from 33% to 25% (P < 0.001). Fewer ART-naive TB patients were initiated on ART in 2009 versus 2007 (57% and 66%, P = 0.031), but this decrease was only in patients with CD4 counts >250 cells per cubic millimeter (19% vs. 48%, P = 0.003). More patients were started on ART during TB treatment (94% vs. 78%, P < 0.001). Moreover, the majority were now initiated during intensive phase (60% vs. 23%, P < 0.001). CONCLUSIONS:Integration of TB and HIV care has led to improved TB treatment outcomes and earlier, prioritized ART initiation. This supports rollout of a fully integrated TB/HIV service delivery model throughout high-prevalence TB and HIV settings.
doi_str_mv 10.1097/QAI.0b013e318251aeb4
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3396431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1016672805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5184-459bd6d888be9bfc5060c337016b9397f6294878e8629a1e5617612d857c97993</originalsourceid><addsrcrecordid>eNqNks1uEzEUhUcIREvhDRCyxIZNij3-3yCFqNCRIhVKwtbyTG4Slxk7tWdSwZvwtniaUkEXiJWvdb57rq91iuIlwacEa_n287Q6xTUmFChRJScWavaoOCaasYlUij3ONS_5hBHKj4pnKV1hTARj-mlxVJZUcyHJcfGz8j1sou1d8Cis0Xn1FVm_Qov36AvEvWsgoUtIQ9sn5Dyqul0Me7jVFxFs34Hv0cXQN6HL5Nh5ZmPrIKJP0YXoevcj09PLBap8vhzmZCOL5jZuAC1jbf3t1FnrvGtGbbnJPvZ58WRt2wQv7s6TYvnhbDE7n8wvPlaz6XzScKLYhHFdr8RKKVWDrtcNxwI3lMq8a62plmtRaqakApULS4ALIgUpV4rLRkut6Unx7uC7G-oOVk1eKNrW7KLrbPxugnXmb8W7rdmEvaFUC0ZJNnhzZxDD9QCpN51LDbSt9RCGZAguFS6ZpPQ_UCKEzDjP6OsH6FUYos8_MVJSCMzEaMgOVBNDShHW9-8m2IwxMTkm5mFMcturP3e-b_qdiwyoA3AT2h5i-tYONxDNFmzbb__t_Qtyh8qt</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017660463</pqid></control><display><type>article</type><title>Integration of HIV and TB Services Results in Improved TB Treatment Outcomes and Earlier Prioritized ART Initiation in a Large Urban HIV Clinic in Uganda</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Free E- Journals</source><source>Journals@Ovid Complete</source><creator>Hermans, Sabine M ; Castelnuovo, Barbara ; Katabira, Catherine ; Mbidde, Peter ; Lange, Joep M A ; Hoepelman, Andy I M ; Coutinho, Alex ; Manabe, Yukari C</creator><creatorcontrib>Hermans, Sabine M ; Castelnuovo, Barbara ; Katabira, Catherine ; Mbidde, Peter ; Lange, Joep M A ; Hoepelman, Andy I M ; Coutinho, Alex ; Manabe, Yukari C</creatorcontrib><description>BACKGROUND:The World Health Organization recommends that treatment of tuberculosis (TB) in HIV-infected patients should be integrated with HIV care. In December 2008, a separate outdoor-integrated TB/HIV clinic was instituted for attendees of a large urban HIV clinic in Uganda. We sought to evaluate associated TB and HIV treatment outcomes. METHODS:Routinely collected clinical, pharmacy, and laboratory data were merged with TB clinic data for patients initiating TB treatment in 2009 and with TB register data for patients in 2007. TB treatment outcomes and (timing of) antiretroviral therapy (ART) initiation in ART-naive patients [overall and stratified by CD4+ T cell (CD4) count] in 2007 and 2009 were compared. Nosocomial transmission rates could not be assessed. RESULTS:Three hundred forty-six patients were initiated on TB treatment in 2007 and 366 in 2009. Median CD4 counts at TB diagnosis did not differ. TB treatment cure or completion increased from 62% to 68%, death or default decreased from 33% to 25% (P &lt; 0.001). Fewer ART-naive TB patients were initiated on ART in 2009 versus 2007 (57% and 66%, P = 0.031), but this decrease was only in patients with CD4 counts &gt;250 cells per cubic millimeter (19% vs. 48%, P = 0.003). More patients were started on ART during TB treatment (94% vs. 78%, P &lt; 0.001). Moreover, the majority were now initiated during intensive phase (60% vs. 23%, P &lt; 0.001). CONCLUSIONS:Integration of TB and HIV care has led to improved TB treatment outcomes and earlier, prioritized ART initiation. This supports rollout of a fully integrated TB/HIV service delivery model throughout high-prevalence TB and HIV settings.</description><identifier>ISSN: 1525-4135</identifier><identifier>ISSN: 1944-7884</identifier><identifier>EISSN: 1944-7884</identifier><identifier>DOI: 10.1097/QAI.0b013e318251aeb4</identifier><identifier>PMID: 22395671</identifier><identifier>CODEN: JDSRET</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Adult ; Ambulatory Care Facilities - organization &amp; administration ; Antiretroviral drugs ; Antiretroviral Therapy, Highly Active ; Antitubercular Agents - administration &amp; dosage ; Cohort Studies ; Female ; HIV ; HIV Infections - complications ; HIV Infections - drug therapy ; Human immunodeficiency virus ; Humans ; Indexing in process ; Integration ; Male ; Middle Aged ; Retrospective Studies ; T cell receptors ; Treatment Outcome ; Tuberculosis ; Tuberculosis - complications ; Tuberculosis - drug therapy ; Uganda ; Urban areas ; Urban Population</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2012-06, Vol.60 (2), p.e29-e35</ispartof><rights>2012 Lippincott Williams &amp; Wilkins, Inc.</rights><rights>Copyright Lippincott Williams &amp; Wilkins Jun 1, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5184-459bd6d888be9bfc5060c337016b9397f6294878e8629a1e5617612d857c97993</citedby><cites>FETCH-LOGICAL-c5184-459bd6d888be9bfc5060c337016b9397f6294878e8629a1e5617612d857c97993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22395671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hermans, Sabine M</creatorcontrib><creatorcontrib>Castelnuovo, Barbara</creatorcontrib><creatorcontrib>Katabira, Catherine</creatorcontrib><creatorcontrib>Mbidde, Peter</creatorcontrib><creatorcontrib>Lange, Joep M A</creatorcontrib><creatorcontrib>Hoepelman, Andy I M</creatorcontrib><creatorcontrib>Coutinho, Alex</creatorcontrib><creatorcontrib>Manabe, Yukari C</creatorcontrib><title>Integration of HIV and TB Services Results in Improved TB Treatment Outcomes and Earlier Prioritized ART Initiation in a Large Urban HIV Clinic in Uganda</title><title>Journal of acquired immune deficiency syndromes (1999)</title><addtitle>J Acquir Immune Defic Syndr</addtitle><description>BACKGROUND:The World Health Organization recommends that treatment of tuberculosis (TB) in HIV-infected patients should be integrated with HIV care. In December 2008, a separate outdoor-integrated TB/HIV clinic was instituted for attendees of a large urban HIV clinic in Uganda. We sought to evaluate associated TB and HIV treatment outcomes. METHODS:Routinely collected clinical, pharmacy, and laboratory data were merged with TB clinic data for patients initiating TB treatment in 2009 and with TB register data for patients in 2007. TB treatment outcomes and (timing of) antiretroviral therapy (ART) initiation in ART-naive patients [overall and stratified by CD4+ T cell (CD4) count] in 2007 and 2009 were compared. Nosocomial transmission rates could not be assessed. RESULTS:Three hundred forty-six patients were initiated on TB treatment in 2007 and 366 in 2009. Median CD4 counts at TB diagnosis did not differ. TB treatment cure or completion increased from 62% to 68%, death or default decreased from 33% to 25% (P &lt; 0.001). Fewer ART-naive TB patients were initiated on ART in 2009 versus 2007 (57% and 66%, P = 0.031), but this decrease was only in patients with CD4 counts &gt;250 cells per cubic millimeter (19% vs. 48%, P = 0.003). More patients were started on ART during TB treatment (94% vs. 78%, P &lt; 0.001). Moreover, the majority were now initiated during intensive phase (60% vs. 23%, P &lt; 0.001). CONCLUSIONS:Integration of TB and HIV care has led to improved TB treatment outcomes and earlier, prioritized ART initiation. This supports rollout of a fully integrated TB/HIV service delivery model throughout high-prevalence TB and HIV settings.</description><subject>Adult</subject><subject>Ambulatory Care Facilities - organization &amp; administration</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Antitubercular Agents - administration &amp; dosage</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Indexing in process</subject><subject>Integration</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>T cell receptors</subject><subject>Treatment Outcome</subject><subject>Tuberculosis</subject><subject>Tuberculosis - complications</subject><subject>Tuberculosis - drug therapy</subject><subject>Uganda</subject><subject>Urban areas</subject><subject>Urban Population</subject><issn>1525-4135</issn><issn>1944-7884</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks1uEzEUhUcIREvhDRCyxIZNij3-3yCFqNCRIhVKwtbyTG4Slxk7tWdSwZvwtniaUkEXiJWvdb57rq91iuIlwacEa_n287Q6xTUmFChRJScWavaoOCaasYlUij3ONS_5hBHKj4pnKV1hTARj-mlxVJZUcyHJcfGz8j1sou1d8Cis0Xn1FVm_Qov36AvEvWsgoUtIQ9sn5Dyqul0Me7jVFxFs34Hv0cXQN6HL5Nh5ZmPrIKJP0YXoevcj09PLBap8vhzmZCOL5jZuAC1jbf3t1FnrvGtGbbnJPvZ58WRt2wQv7s6TYvnhbDE7n8wvPlaz6XzScKLYhHFdr8RKKVWDrtcNxwI3lMq8a62plmtRaqakApULS4ALIgUpV4rLRkut6Unx7uC7G-oOVk1eKNrW7KLrbPxugnXmb8W7rdmEvaFUC0ZJNnhzZxDD9QCpN51LDbSt9RCGZAguFS6ZpPQ_UCKEzDjP6OsH6FUYos8_MVJSCMzEaMgOVBNDShHW9-8m2IwxMTkm5mFMcturP3e-b_qdiwyoA3AT2h5i-tYONxDNFmzbb__t_Qtyh8qt</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Hermans, Sabine M</creator><creator>Castelnuovo, Barbara</creator><creator>Katabira, Catherine</creator><creator>Mbidde, Peter</creator><creator>Lange, Joep M A</creator><creator>Hoepelman, Andy I M</creator><creator>Coutinho, Alex</creator><creator>Manabe, Yukari C</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7T5</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120601</creationdate><title>Integration of HIV and TB Services Results in Improved TB Treatment Outcomes and Earlier Prioritized ART Initiation in a Large Urban HIV Clinic in Uganda</title><author>Hermans, Sabine M ; Castelnuovo, Barbara ; Katabira, Catherine ; Mbidde, Peter ; Lange, Joep M A ; Hoepelman, Andy I M ; Coutinho, Alex ; Manabe, Yukari C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5184-459bd6d888be9bfc5060c337016b9397f6294878e8629a1e5617612d857c97993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Ambulatory Care Facilities - organization &amp; administration</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Antitubercular Agents - administration &amp; dosage</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Indexing in process</topic><topic>Integration</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>T cell receptors</topic><topic>Treatment Outcome</topic><topic>Tuberculosis</topic><topic>Tuberculosis - complications</topic><topic>Tuberculosis - drug therapy</topic><topic>Uganda</topic><topic>Urban areas</topic><topic>Urban Population</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hermans, Sabine M</creatorcontrib><creatorcontrib>Castelnuovo, Barbara</creatorcontrib><creatorcontrib>Katabira, Catherine</creatorcontrib><creatorcontrib>Mbidde, Peter</creatorcontrib><creatorcontrib>Lange, Joep M A</creatorcontrib><creatorcontrib>Hoepelman, Andy I M</creatorcontrib><creatorcontrib>Coutinho, Alex</creatorcontrib><creatorcontrib>Manabe, Yukari C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hermans, Sabine M</au><au>Castelnuovo, Barbara</au><au>Katabira, Catherine</au><au>Mbidde, Peter</au><au>Lange, Joep M A</au><au>Hoepelman, Andy I M</au><au>Coutinho, Alex</au><au>Manabe, Yukari C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integration of HIV and TB Services Results in Improved TB Treatment Outcomes and Earlier Prioritized ART Initiation in a Large Urban HIV Clinic in Uganda</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><addtitle>J Acquir Immune Defic Syndr</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>60</volume><issue>2</issue><spage>e29</spage><epage>e35</epage><pages>e29-e35</pages><issn>1525-4135</issn><issn>1944-7884</issn><eissn>1944-7884</eissn><coden>JDSRET</coden><abstract>BACKGROUND:The World Health Organization recommends that treatment of tuberculosis (TB) in HIV-infected patients should be integrated with HIV care. In December 2008, a separate outdoor-integrated TB/HIV clinic was instituted for attendees of a large urban HIV clinic in Uganda. We sought to evaluate associated TB and HIV treatment outcomes. METHODS:Routinely collected clinical, pharmacy, and laboratory data were merged with TB clinic data for patients initiating TB treatment in 2009 and with TB register data for patients in 2007. TB treatment outcomes and (timing of) antiretroviral therapy (ART) initiation in ART-naive patients [overall and stratified by CD4+ T cell (CD4) count] in 2007 and 2009 were compared. Nosocomial transmission rates could not be assessed. RESULTS:Three hundred forty-six patients were initiated on TB treatment in 2007 and 366 in 2009. Median CD4 counts at TB diagnosis did not differ. TB treatment cure or completion increased from 62% to 68%, death or default decreased from 33% to 25% (P &lt; 0.001). Fewer ART-naive TB patients were initiated on ART in 2009 versus 2007 (57% and 66%, P = 0.031), but this decrease was only in patients with CD4 counts &gt;250 cells per cubic millimeter (19% vs. 48%, P = 0.003). More patients were started on ART during TB treatment (94% vs. 78%, P &lt; 0.001). Moreover, the majority were now initiated during intensive phase (60% vs. 23%, P &lt; 0.001). CONCLUSIONS:Integration of TB and HIV care has led to improved TB treatment outcomes and earlier, prioritized ART initiation. This supports rollout of a fully integrated TB/HIV service delivery model throughout high-prevalence TB and HIV settings.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>22395671</pmid><doi>10.1097/QAI.0b013e318251aeb4</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1525-4135
ispartof Journal of acquired immune deficiency syndromes (1999), 2012-06, Vol.60 (2), p.e29-e35
issn 1525-4135
1944-7884
1944-7884
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3396431
source MEDLINE; Journals@Ovid LWW Legacy Archive; Free E- Journals; Journals@Ovid Complete
subjects Adult
Ambulatory Care Facilities - organization & administration
Antiretroviral drugs
Antiretroviral Therapy, Highly Active
Antitubercular Agents - administration & dosage
Cohort Studies
Female
HIV
HIV Infections - complications
HIV Infections - drug therapy
Human immunodeficiency virus
Humans
Indexing in process
Integration
Male
Middle Aged
Retrospective Studies
T cell receptors
Treatment Outcome
Tuberculosis
Tuberculosis - complications
Tuberculosis - drug therapy
Uganda
Urban areas
Urban Population
title Integration of HIV and TB Services Results in Improved TB Treatment Outcomes and Earlier Prioritized ART Initiation in a Large Urban HIV Clinic in Uganda
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A17%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integration%20of%20HIV%20and%20TB%20Services%20Results%20in%20Improved%20TB%20Treatment%20Outcomes%20and%20Earlier%20Prioritized%20ART%20Initiation%20in%20a%20Large%20Urban%20HIV%20Clinic%20in%20Uganda&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Hermans,%20Sabine%20M&rft.date=2012-06-01&rft.volume=60&rft.issue=2&rft.spage=e29&rft.epage=e35&rft.pages=e29-e35&rft.issn=1525-4135&rft.eissn=1944-7884&rft.coden=JDSRET&rft_id=info:doi/10.1097/QAI.0b013e318251aeb4&rft_dat=%3Cproquest_pubme%3E1016672805%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017660463&rft_id=info:pmid/22395671&rfr_iscdi=true